However, the over-expression of survivin was not associated with clinical characteristics, such as age, sex, FAB subtype, or laboratory parameters (Table 1), indicating that survivin could be an independent factor for diagnosis or prognosis of AML. The gene discussed is BIRC5; the disease is acute myeloid leukemia.